AVALON GLOBOCARE CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2728 USD | -2.57% |
|
-10.70% | -43.52% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering transformative, precision diagnostics and clinical laboratory services. The Company offers diagnostic testing utilizing proprietary technology to deliver genetics-driven results. It operates through two segments: Real property rental and Lab Services MSO. Lab Services MSO segment is focused on delivering services related to toxicology and wellness testing and provides a portfolio of diagnostic tests including drug testing, toxicology, and a range of test services, from general bloodwork to anatomic pathology, and urine toxicology. Its capabilities include STAT blood testing, qualitative drug screening, genetic testing, urinary testing, and sexually transmitted disease testing. Lab Services MSO segment is also focused on the commercialization of genetic-based proprietary testing. It is also exploring the commercialization and development of a versatile breathalyzer system, KetoAir breathalyzer.
| 1st Jan change | Capi. | |
|---|---|---|
| -43.52% | 3.03M | |
| -17.89% | 8.25B | |
| +39.20% | 3.57B | |
| -39.11% | 2.46B | |
| -8.06% | 2.46B | |
| -7.35% | 2.38B | |
| -12.61% | 1.81B | |
| -19.01% | 1.55B | |
| -40.66% | 1.21B | |
| +7.56% | 1.11B |
- Stock Market
- Equities
- ALBT Stock
- News Avalon GloboCare Corp.
- Avalon Says Laboratory Services Launches New Tuberculosis Test; Shares Rise
